These results suggested that in doxorubicin-induced cardiomyopathy, upregulated TRAF3 may bind to TAK1 and promote its phosphorylation, thereby inducing downstream activation of JNK, P38 MAPK, ERK and eliciting doxorubicin cardiotoxicity. This evidence concerns the gene MAPK8 and cardiomyopathy.